The predictive value of PET-CT and PET-DW-MRI early during chemoradiotherapy for locoregional control of advanced stage head and neck cancer

Completed

• Conditions: head and neck cancer; head and neck squamous cell carcinoma; 10027655

• Registration Number: NL-OMON41220
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

patients with resectable advanced (stage III and IV) HNSCC scheduled for primary non-surgical treatment (chemoradiotherapy) with curative intent.

Exclusion Criteria

technically inoperable tumor
every condition making MRI imposssible

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Criteria for predicting locoregional response and accuracy of FDG-PET-CT and<br /><br>DW-MRI (EPI and non-EPI technique). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Feasibility of PET-MRI.</p><br>